“As part of the EDISON Alliance’s 1 Billion Lives Challenge, AstraZeneca, along with Qure.ai, will be screening 5 million patients by 2025. We look forward to deepening collaboration to accelerate scalable and affordable digital solutions to help improve access to healthcare and transform patient outcomes, especially in underserved communities.”
"Our partnership with Qure.ai represents a critical step in our commitment to the EDISON Alliance's 1 Billion Lives Challenge. Lung cancer remains a major global health concern, and through applying AI to screen for lung cancer risk in millions of routine X-rays, it will provide a low-cost, high-impact way of ensuring at-risk patients enter the right diagnostic and care pathway. This milestone exemplifies our A.Catalyst Network approach to expanding access to digital healthcare and making change in the communities we serve."